drugset
drugset / Trial / NCT01915771

Study to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects

NCT01915771 ↗

Phase 1 Completed 15 enrolled Aegerion Pharmaceuticals, Inc.
NaSingle-groupOpen-labelOther

Summary

Objectives: To evaluate the intra-subject variability of the pharmacokinetics (PK) of single oral capsule doses of 20 mg lomitapide.

Timeline

Start
2013-07-29
Primary completion
2013-08-23
Completion
2013-08-23

Drugs

EvaluationDrugModalityDoseRoute
Subject lomitapide Small molecule 20 mg Oral

Indications

No indication recorded.